Literature DB >> 31081266

Human placenta-derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1α pathway in autoimmune POF mice.

Hongxing Li1, Wei Zhao1, Li Wang2, Qianqian Luo3, Na Yin1, Xueyan Lu1, Yun Hou1, Jingjing Cui2, Hongqin Zhang1.   

Abstract

Previous studies have shown that the ovarian failure in autoimmune-induced premature ovarian failure (POF) mice could be improved by the transplantation of human placenta-derived mesenchymal stem cells (hPMSCs); however, the protective mechanism of hPMSCs transplantation on ovarian dysfunction remains unclear. Ovarian dysfunction is closely related to the apoptosis of granulosa cells (GCs). To determine the effects of hPMSCs transplantation on GCs apoptosis, an autoimmune POF mice model was established with zona pellucida glycoprotein 3 (ZP3) peptide. It is reported that the inositol-requiring enzyme 1α (IRE1α) and its downstream molecules play a central role in the endoplasmic reticulum (ER) stress-induced apoptosis pathway. So the aim of this study is to investigate whether hPMSCs transplantation attenuated GCs apoptosis via inhibiting ER stress IRE1α signaling pathway. The ovarian dysfunction, follicular dysplasia, and GCs apoptosis were observed in the POF mice. And the IRE1α pathway was activated in ovaries of POF mice, as demonstrated by, increased X-box binding protein 1 (XBP1), up-regulated 78 kDa glucose-regulated protein (GRP78) and caspase-12. Following transplantation of hPMSCs, the ovarian structure and function were significantly improved in POF mice. In addition, the GCs apoptosis was obviously attenuated and IRE1α pathway was significantly inhibited. Transplantation of hPMSCs suppressed GCs apoptosis-induced by ER stress IRE1α signaling pathway in POF mice, which might contribute to the hPMSCs transplantation-mediating ovarian function recovery.
© 2019 International Federation for Cell Biology.

Entities:  

Keywords:  IRE1α; apoptosis; endoplasmic reticulum stress; granulosa cells; human placenta-derived mesenchymal stem cell; premature ovarian failure

Mesh:

Substances:

Year:  2019        PMID: 31081266     DOI: 10.1002/cbin.11165

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  12 in total

Review 1.  Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.

Authors:  Oldouz Shareghi-Oskoue; Leili Aghebati-Maleki; Mehdi Yousefi
Journal:  Stem Cell Res Ther       Date:  2021-08-11       Impact factor: 8.079

2.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNA-29a Improves Ovarian Function of Mice with Primary Ovarian Insufficiency by Targeting HMG-Box Transcription Factor/Wnt/β-Catenin Signaling.

Authors:  Tian Gao; Yi Cao; Min Hu; Ying Du
Journal:  Dis Markers       Date:  2022-07-02       Impact factor: 3.464

3.  MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF- κB signaling pathway.

Authors:  Fengping He; Yanhui Liu; Tang Li; Qiulin Ma; Zhang Yongmei; Peiqing He; Chuanyin Xiong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 4.  Is It Possible to Treat Infertility with Stem Cells?

Authors:  P Petric; E Vrtacnik-Bokal; M Stimpfel
Journal:  Reprod Sci       Date:  2021-04-08       Impact factor: 3.060

Review 5.  Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review.

Authors:  Jeeyoon Na; Gi Jin Kim
Journal:  J Ovarian Res       Date:  2020-06-23       Impact factor: 4.234

Review 6.  Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities.

Authors:  Yun-Xing Fu; Jing Ji; Fang Shan; Jialing Li; Rong Hu
Journal:  Stem Cell Res Ther       Date:  2021-03-03       Impact factor: 6.832

7.  Exploration of the Danggui Buxue Decoction Mechanism Regulating the Balance of ESR and AR in the TP53-AKT Signaling Pathway in the Prevention and Treatment of POF.

Authors:  Huaiquan Liu; Hong Yang; Zhong Qin; Yunzhi Chen; Haiyang Yu; Wen Li; Xing Zhu; Jingwen Cai; Jing Chen; Mengzhi Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-30       Impact factor: 2.629

Review 8.  Therapeutic options for premature ovarian insufficiency: an updated review.

Authors:  Qiao-Yi Huang; Shao-Rong Chen; Jia-Ming Chen; Qi-Yang Shi; Shu Lin
Journal:  Reprod Biol Endocrinol       Date:  2022-02-04       Impact factor: 5.211

Review 9.  Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility.

Authors:  Sahar Esfandyari; Rishi Man Chugh; Hang-Soo Park; Elie Hobeika; Mara Ulin; Ayman Al-Hendy
Journal:  Cells       Date:  2020-10-08       Impact factor: 6.600

Review 10.  Application of Stem Cell Therapy for Infertility.

Authors:  Sarama Saha; Partha Roy; Cynthia Corbitt; Sham S Kakar
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.